Is Cryogenic OGS overvalued or undervalued?
2025-10-20 08:10:10As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its key financial ratios, including a PE ratio of 42.91, an EV to EBITDA ratio of 29.49, and a Price to Book Value of 5.23. When compared to its peers, Cryogenic OGS stands out with a higher PE ratio than Thermax at 55.98 and BEML Ltd at 61.47, both of which are also classified as very expensive. The company has shown strong returns over the past week and month, outperforming the Sensex with a stock return of 17.08% and 22.98%, respectively. However, despite these short-term gains, the overall valuation suggests that Cryogenic OGS is not a favorable investment at its current price of 183.00....
Read MoreIs Cryogenic OGS overvalued or undervalued?
2025-10-19 08:09:50As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued based on its high ratios, including a PE ratio of 42.91, an EV to EBITDA of 29.49, and an EV to Sales of 7.14. These figures suggest that investors are paying a premium for the stock relative to its earnings and sales. In comparison to its peers, Cryogenic OGS's PE ratio is notably lower than Thermax's 55.98 and BEML Ltd's 61.47, both of which are also categorized as very expensive. However, the PEG ratio of Cryogenic OGS stands at 0.00, indicating a lack of growth expectations, which further supports the conclusion of overvaluation. Despite recent stock performance showing a 17.08% return over the past week compared to a mere 1.76% for the Sensex, the overall valuation metrics suggest that the s...
Read MoreIs Cryogenic OGS overvalued or undervalued?
2025-10-18 08:09:44As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive. The company is currently overvalued based on its high valuation multiples, including a PE ratio of 42.91, an EV to EBITDA of 29.49, and an EV to EBIT of 31.55. These figures significantly exceed those of its peers, such as Thermax with a PE of 55.98 and an EV to EBITDA of 36.86, and Action Construction Equipment with a PE of 30.65 and an EV to EBITDA of 25.09. In comparison to its industry, Cryogenic OGS's PEG ratio is notably at 0.00, indicating a lack of growth relative to its price, which further supports the conclusion of overvaluation. Additionally, the company's recent stock performance has outpaced the Sensex, with a 1-week return of 17.08% compared to the Sensex's 1.76%, but this does not mitigate the overall valuation concerns....
Read MoreHow has been the historical performance of Cryogenic OGS?
2025-10-16 22:43:20Answer: The historical performance of Cryogenic OGS shows a steady growth in net sales and profitability over the past three years. Breakdown: Cryogenic OGS has demonstrated a consistent increase in net sales, rising from 22.02 Cr in Mar'23 to 24.25 Cr in Mar'24, and further to 32.90 Cr in Mar'25. Total operating income mirrored this trend, reaching 32.90 Cr in Mar'25. However, raw material costs also increased significantly, from 11.70 Cr in Mar'23 to 21.26 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 16.37 Cr in Mar'23 to 24.94 Cr in Mar'25, yet the operating profit (PBDIT) improved from 6.34 Cr in Mar'23 to 8.85 Cr in Mar'25. Profit before tax also saw an upward trajectory, increasing from 5.48 Cr in Mar'23 to 8.27 Cr in Mar'25, while profit after tax rose from 4.08 Cr to 6.09 Cr in the same period. The earnings per share (EPS) increased from 3.89 in Mar'23 to 5.8 in Mar'25. On...
Read MoreAnnouncement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
25-Nov-2025 | Source : BSEWe are pleased to inform you that Cryogenic OGS Limited has received an LOI from Advanced Sys-Tek Limited amounting to Rs. 9766448/-.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13-Nov-2025 | Source : BSEWe would like to inform you that the scheduled plant visit of the analysts/ investors at the registered office of the Company had been conducted during 12:00 PM to 4:00 PM (IST).
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Nov-2025 | Source : BSEWe would like to inform you that the Board of Directors of the Company will be organising plant visit for the analysts/ investors at the registered office of the Company on 13th November 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






